Jean-Yves Pavee, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,768 shares at $47.48 ($84K) on 2015-03-02, disclosed to the SEC on 2015-03-03.
Scheduled sale ($84k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.61 | 1,116 | $53K | 63.2% |
| 2 | $47.48 | 652 | $31K | 36.8% |
| Total | $47.56 avg | 1,768 | $84K | 100% |
| Filing → |
| ABT | SELL | 2015-06-05 | $515K | — | Filing → |
| ABT | SELL | 2015-02-18 | $29K | — | Filing → |
| ABT | SELL | 2014-02-19 | $19K | — | Filing → |